SCHEMBL898462

SCHEMBL898462

COc1ccc(CNCC(N)O)cc1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 2/20 0.66
ERAP2 Q6P179 2/20 0.66
DNM1 Q05193 1/20 0.53
CHRM2 P08172 1/20 0.53
ALDH1A1 P00352 1/20 0.50
PKM P14618 1/20 0.50
TSHR P16473 1/20 0.50
SLC6A4 P31645 1/20 0.49
DPP7 Q9UHL4 2/20 0.48
AOC3 Q16853 1/20 0.47
ADRB3 P13945 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ATM Q13315 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14218498 0.89 ANPEP (0.65) ANPEPERAP2DNM1CHRM2ALDH1A1
SCHEMBL6492794 0.84 ANPEP (0.59) ANPEPERAP2DNM1CHRM2ALDH1A1
SCHEMBL6499108 0.84 ANPEP (0.59) ANPEPERAP2DNM1CHRM2ALDH1A1
SCHEMBL15819968 0.84 ANPEP (0.59) ANPEPERAP2DNM1CHRM2ALDH1A1
SCHEMBL17504540 0.84 ANPEP (0.63) ANPEPERAP2DNM1CHRM2ALDH1A1
SCHEMBL21245400 0.84 ANPEP (0.63) ANPEPERAP2DNM1CHRM2ALDH1A1
SCHEMBL3680963 0.81 DNM1 (0.59) ANPEPERAP2DNM1CHRM2ALDH1A1
SCHEMBL23367774 0.80 ANPEP (0.58) ANPEPERAP2DNM1CHRM2ALDH1A1
Hydrochloric Acid SCHEMBL10276533 0.80 ANPEP (0.58) ANPEPERAP2DNM1CHRM2ALDH1A1
Hydrochloric Acid SCHEMBL10276301 0.80 ANPEP (0.58) ANPEPERAP2DNM1CHRM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012042534-A2 PROCESSES FOR THE PREPARATION OF R-SITAGLIPTIN AND INTERMEDIATES THEREOF GLENMARK GENERICS LIMITED (IN) 2012-04-05 WO claimed
WO-2012042534-A2 PROCESSES FOR THE PREPARATION OF R-SITAGLIPTIN AND INTERMEDIATES THEREOF GLENMARK GENERICS LIMITED (IN) 2012-04-05 WO disclosed